Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease (Q46432570)
Jump to navigation
Jump to search
scientific article published in January 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease |
scientific article published in January 2005 |
Statements
1 reference
Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease (English)
1 reference
Yamagishi S
1 reference
Nakamura K
1 reference
Inoue H
1 reference
Kikuchi S
1 reference
Takeuchi M
1 reference
1 January 2005
1 reference
1 reference
64
1 reference
6
1 reference
1205-1207
1 reference
Identifiers
1 reference
1 reference